Rubella was not recognised as a disease of major importance until 1941, when the historic work of Sir Norman Gregg correlated infection during pregnancy with damage to the child in utero (Gregg, 1941) . Fetal damage induced by rubella occurs in up to 35 % of cases if infection of the mother occurs in the first trimester of pregnancy, but later infections may produce sequelae, although damage is less severe and less frequent. The pathogenesis, the incidence of specific malformations and defects, and the risks to the fetus are fully described by Hanshaw and Dudgeon (1978) , who also discuss preventive measures. In an attempt to reduce or eliminate the problem of fetal damage due to rubella, a vaccine programme was launched in the United Kingdom in 1970 and a National Congenital Rubella Surveillance Programme was initiated in the following year. Hanshaw and Dudgeon have observed that the final test of protective efficacy of a vaccine is in the population as a whole. We report here the influence of the national vaccination programme on susceptibility to rubella in the population served by Queen Charlotte's Hospital, together with observations on the results of offering vaccine in the puerperium to women adjudged to be non-immune.
Material and methods
Specimens of blood are collected routinely from all patients who book for antenatal care. This is usually at 12-16 weeks' gestation. Serum is separated and screened for antibody to rubella virus using a rubella haemagglutination inhibition technique (Beazley et al., 1971) .
Results

LEVELS OF IMMUNITY IN THE POPULATION
A total of 3000-5000 patients were screened per annum between 1971 and 1977. Analysis of the results obtained for a number of years during this period shows no clear trend of decreasing susceptibility which can be attributed to the vaccine (Table 1) .
A total of 3338 women were screened in 1977. The country of origin was ascerta two age groups: 22% of the 15 born outside the United Kingdon the 20-24-year-olds. Immunity i] compared in Table 3 . In an attempt to reduce or eliminate the problem of rubella in pregnancy in the United Kingdom, a vaccine programme was instituted in 1970. Originally Lined in patients in offering vaccine to all girls between 11 and 14 years -19-year-olds were of age, it was later extended to include some nonn, as were 26 % of pregnant women of child-bearing age who were n these groups is known to Table 3 shows the influence of women born outside the United Kingdom on overall levels of immunity for two age groups in 1977. Those born outside the United Kingdom and aged 20-24 years show a lower level of immunity than those born within the United Kingdom. This is not seen in the younger group. Data on length of residence in the United Kingdom were not available. Comparison of those born within the United Kingdom shows little difference in the proportion with immunity in each age group.
However, statistical analysis of the figures presented inTable 3 does not confirm observed differences as having a high order of significance. Chi squared was calculated from a fourfold table using Yates' correction, and no significant difference was discernible between the age groups as a whole, between the two populations making up each group, or by comparing like populations within different age groups.
The availability of vaccine, which should have been offered to those in the younger group, does not appear to have influenced overall the proportion of women possessing rubella haemagglutination inhibition antibody assessed at a serum dilution of 1/16. Although an effect is discernible in the group aged 15-19 years (Table 2) , it is not statistically significant. Table 4 shows that vaccination in the puerperium gives a similar incidence of immunity when assessed at a serum dilution of 1/16 to that seen in the United Kingdom born population (Table 3) . However, when assessed at 1/64, a level of antibody believed to confer substantial immunity (Horstman, 1976) , comparison with the general population shows a significant difference (X2 fourfold test P < 0.001).
Only 35.1 % of vaccinees have antibody as opposed to approximately 50% of the general population (Table 2) .
Our assessment of immunity is made six weeks after vaccination, and we would expect titres to fall even from these levels over a number of years. Support for this view is given by other workers (Balfour and Amren, 1977) . Davis et al. (1971) have shown that 25% of low responders (1/16 or less) have lost detectable rubella haemagglutination inhibition antibody (less than 1/8) five years after vaccination.
Thus, with 100% acceptance of vaccine and the titres that resulted ( where an estimated national acceptance of rubella vaccine of at least 64% is achieved (Public Health Laboratory Service, unpublished report). That the difference is not greater could be attributed to the effect of natural infection, but overall no antibody boosting effect due to this could be discerned (Table 2) . Where vaccinated individuals remain, or lapse, to become seronegative, it is unclear how susceptible they are to clinical rubella. Further studies in the laboratory and in the community are required to elucidate whether it is possible for vaccination to remove the problem of rubella in pregnancy or merely to reduce it. We have found no evidence of increased availability of vaccine causing significant change in the immunity of the population studied.
Recently, Ross and McCartney (1979) have published evidence that the high incidence of rubella in Scotland during 1978 had a booster effect on levels of antibody but we have found no hard evidence of this occurring in this study in a non-epidemic year. 
